.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Julphar
UBS
Colorcon
McKesson
Chinese Patent Office
Cantor Fitzgerald
Cipla
Deloitte
McKinsey

Generated: July 28, 2017

DrugPatentWatch Database Preview

DOXERCALCIFEROL Drug Profile

« Back to Dashboard

What is the patent landscape for Doxercalciferol, and when can generic versions of Doxercalciferol launch?

Doxercalciferol is a drug marketed by Hikma Pharms Llc, Rising Pharms Inc, Sandoz Inc, Akorn Inc, West-ward Pharms Int, and Amneal Pharms Co. and is included in eight NDAs.

The generic ingredient in DOXERCALCIFEROL is doxercalciferol. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the doxercalciferol profile page.

Summary for Tradename: DOXERCALCIFEROL

Patents:0
Applicants:6
NDAs:8
Suppliers / Packagers: see list6
Bulk Api Vendors: see list34
Clinical Trials: see list16
Patent Applications: see list241
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOXERCALCIFEROL at DailyMed

Pharmacology for Tradename: DOXERCALCIFEROL

Ingredient-typeErgocalciferols
Drug ClassVitamin D2 Analog
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms Llc
DOXERCALCIFEROL
doxercalciferol
INJECTABLE;INJECTION091101-001Aug 30, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Akorn Inc
DOXERCALCIFEROL
doxercalciferol
INJECTABLE;INJECTION203929-001May 7, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Rising Pharms Inc
DOXERCALCIFEROL
doxercalciferol
CAPSULE;ORAL201518-003Sep 9, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms Co
DOXERCALCIFEROL
doxercalciferol
INJECTABLE;INJECTION208974-001May 24, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
DOXERCALCIFEROL
doxercalciferol
CAPSULE;ORAL091433-001Sep 23, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Novartis
US Department of Justice
Julphar
McKesson
Farmers Insurance
US Army
Citi
Express Scripts
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot